Filters

PSCA Antibody, Cy7 Conjugated

PSCA Antibody, Cy7 Conjugated size: 0.1ml 350

Price 350
Size 0.1ml
Long name Cy7 Conjugated, PSCA Polyclonal Antibody
CategoryConjugated Primary Antibodies
ConjugationCy7
Host OrganismRabbit (Oryctolagus cuniculus)
Target AntigenPSCA
SpecificityThis is a highly specific antibody against PSCA
ModificationUnmodified
Modification siteNone
ClonalityPolyclonal
ClonePolyclonal antibody
Concentration1ug per 1ul
Immunogen_range5-55/123
Subcellular locationCell membrane
SourceKLH conjugated synthetic peptide derived from human PSCA
Gene ID number8000
Swiss ProtO43653
Tested applicationsIF(IHC-P)
Recommended dilutionsIF(IHC-P)(1:50-200)
CrossreactivityHuman
Crossreactive species details not every possible cross-reactivity is known, Due to limited amount of testing and knowledge
Antigen background Has a cell-proliferation inhibition activity in vitro, May be involved in the regulation of cell proliferation
Purification methodThis antibody was purified via Protein A
Storage conditions 50% glycerol and 0, Store refrigerated at 2 to 8 degrees Celcius for up to 1 year, 09% sodium azide, Keep the antibody in an aqueous buffered solution containing 1% BSA
Excitation Emission743nm/767nm
PropertiesC, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Conjugated Antibodies they should be stored frozen at - 24°
ConjugatedThese antibodies are excite for emission at 650 nm and detected at a 676 nm wavelengths
Gene targetPSCA Conjugated
Short name Conjugated, PSCA Antibody
Technique antibodies against human proteins, antibodies for, antibody Conjugates, Antibody
LabelCy7
Alternative name cyanine 7 coupled, PSCA (Antibody to)
Alternative techniqueantibodies
Identity 9500
Gene PSCA
Long gene name prostate stem cell antigen
Locus 8q24, 3
Discovery year 1999-08-25
GenBank acession AF043498
Entrez gene record 8000
Pubmed identfication 9465086
RefSeq identity NM_005672
Classification LY6/PLAUR domain containing
Havana BLAST/BLAT OTTHUMG00000162077

Subscribe to our Newsletter